APA

Bright S. A., Byrne A. J., Vandenberghe E., Browne P. V., Mcelligott A. M., Meegan M. J. & Williams D. C. (20190624). Selected nitrostyrene compounds demonstrate potent activity in chronic lymphocytic leukaemia cells, including those with poor prognostic markers. : Oncology reports.

Chicago

Bright S A, Byrne A J, Vandenberghe E, Browne P V, Mcelligott A M, Meegan M J and Williams D C. 20190624. Selected nitrostyrene compounds demonstrate potent activity in chronic lymphocytic leukaemia cells, including those with poor prognostic markers. : Oncology reports.

Harvard

Bright S. A., Byrne A. J., Vandenberghe E., Browne P. V., Mcelligott A. M., Meegan M. J. and Williams D. C. (20190624). Selected nitrostyrene compounds demonstrate potent activity in chronic lymphocytic leukaemia cells, including those with poor prognostic markers. : Oncology reports.

MLA

Bright S A, Byrne A J, Vandenberghe E, Browne P V, Mcelligott A M, Meegan M J and Williams D C. Selected nitrostyrene compounds demonstrate potent activity in chronic lymphocytic leukaemia cells, including those with poor prognostic markers. : Oncology reports. 20190624.